Effect of parathyroidectomy on anemia in chronic renal failure
- 1 August 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 139 (8) , 889-891
- https://doi.org/10.1001/archinte.139.8.889
Abstract
Fourteen patients with chronic renal failure underwent parathyroidectomy. Postoperatively, 7 patients exhibited a rise in hematocrit reading, but 7 others did not. Responders had more severe bone disease and lower initial hematocrit values than did nonresponders. Marrow fibrosis was slightly more prominent in responders. Current concepts of marrow erythropoietic inhibition in renal failure suggest a toxic serum factor as the cause. Parathyroid hormone may not be the toxic agent directly responsible for marrow inhibition. Parathyroid hormone may contribute to anemia in renal failure by causing marrow fibrosis, a process sometimes reversible by successful therapy of hyperparathyroidism.This publication has 5 references indexed in Scilit:
- ANEMIA OF CHRONIC RENAL-FAILURE - STUDIES OF EFFECT OF ORGANIC-SOLVENT EXTRACTION OF SERUM1978
- Hemosiderosis Secondary to Chronic Parenteral Iron Therapy in Maintenance Hemodialysis PatientsNephron, 1978
- Myelofibrosis and renal osteodystrophyThe American Journal of Medicine, 1977
- Anemia in primary hyperparathyroidismArchives of internal medicine (1960), 1977
- Is Parathyroid Hormone a Uremic Toxin?Nephron, 1977